Increased expression of NRP2 results in down-regulation of EGFR, slowed tumor growth, and suppression of an EGFR “rescue” pathway of tumor cells, which is turned on as a protective response to MET-directed tumor therapy [188]. Here, MET is linked to neoplasm.